This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bioline Launches New Products For Epigenetics Research

Stocks in this article: VIVO

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), announces that it has entered the rapidly growing Epigenetics field, with the launch of the first kits in the new EPIK™ product range; EPIK™ Fast Quantification Kit and EPIK™ Amplification Kit.

These EPIK TM Kits have been developed to meet the needs of researchers employing PCR and real-time PCR analysis in Epigenetics, by delivering significantly increased reliability and sensitivity. Currently the majority of techniques used in Epigenetics have been found to be unreliable and not reproducible. Methylation of DNA is one of the best-studied epigenetic phenomena with bisulfite-modification of DNA considered to be the best method to study DNA methylation patterns. The EPIK™ Kits are based on the highly sensitive, and customer proven, MyTaq™ and SensiFAST™ polymerases together with a novel EPIKORE™ buffer system, formulated to overcome the challenges associated with bisulfite-modified DNA templates. The high-speed, enhanced specificity and outstanding reliability of the EPIK™ Kits makes them perfectly suited to high-throughput epigenetic analysis.

Marco Calzavara, President of Bioline, said, “Epigenetic changes alter the physical structure of DNA and can turn genes on or off. Strong links have been identified between Epigenetics, aging and cancer; consequently there is a lot of active research in this rapidly growing field. Our customers have told us that reliability is a major issue in Epigenetic analysis, and with the launch of these new kits, we will bring new levels of reproducibility and sensitivity to this field.”

Richard L. Eberly, President of Meridian Life Science, Inc., stated, “We are delighted with the launch of this new product range. Researchers world-wide will now have greater confidence in their results, as they push the boundaries of Epigenetics understanding. The EPIK TM range is a further demonstration of our commitment to our life science customers and to bringing innovation and quality products to the research laboratory, clinical diagnostic laboratories, and biotechnology companies.”


1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs